Kodiak Sciences Inc (FRA:K27)
€ 3.546 0.072 (2.07%) Market Cap: 211.94 Mil Enterprise Value: 80.00 Mil PE Ratio: 0 PB Ratio: 0.96 GF Score: 37/100

Kodiak Sciences Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 04:55PM GMT
Release Date Price: €1.92 (-2.41%)
Unidentified Analyst

Good afternoon, everyone, and thanks for joining us on Day 3 of Morgan Stanley Global Healthcare Conference. I'm Michael [Olson] of biotech analyst here. It's my pleasure to introduce Victor Perlroth, CEO of Kodiak Sciences. Just a reminder of the format for today, the fireside chat. Before we get started, I just need to read a quick disclosure. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

With that, Victor, thanks for joining us. And I thought maybe if you could just start off with an overview of where Kodiak is today as a company, and we'll go from there.

Questions & Answers

Victor Perlroth
Kodiak Sciences Inc. - Co-Founder, Chairman, CEO & President

Thanks a lot, Mike. It's good to be here. First of all, I may make forward-looking statements, so please

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot